In type 1 diabetes, apelin therapy (400 pmol/kg) for 10 weeks enhanced pancreatic islet mass, insulin content, and reduced endoplasmic reticulum stress in the pancreatic islets (146). Here, APLN is linked to type 1 diabetes mellitus.